ERBB2 and breast cancer: Tam-loaded PVP–PLGA NPs and herceptin-conjugated Tam-loaded PVP–PLGA NPs, which target HER2, have been found to treat multi-drug-resistant breast cancer, and the Nb targeting F-actin capping protein CapG inhibits cancer metastasis in animal models of breast cancer25,26.